Di-2-ethylhexylphthalate contributes to 13.497% of all cardiovascular deaths among individuals aged 55 to 64 years with considerable geographic disparities.

Urinary incontinence is not associated with moderate-to-vigorous physical activity classification but is associated with CVD risk factors and comorbidity.

Individualized approaches may enhance the safety and efficacy of music for pain management in health care settings.

A no-touch vein harvesting technique reduces vein graft occlusion and improves patient outcomes at 3-year follow-up among patients undergoing CABG surgery.

In racially and socioeconomically marginalized pediatric patients there are significant inequities in the incidence of HER behavioral flags.

There is increased risk for stroke among women experiencing homelessness and unstable housing who have cocaine and alcohol co-use.

Decreases in global cognition and executive function, as well as long-term persistent declines in those cognitive domains, are associated with incident HF.

Despite widespread vaccine availability and improved treatment strategies, certain patients with SARDs remain highly vulnerable to severe COVID-19 outcomes.

For patients with metabolic dysfunction-associated steatohepatitis and fibrosis, semaglutide is associated with improved liver histologic outcomes.

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

For patients with carotid stenosis ≥50% with a low/intermediate predicted stroke risk, there is no benefit for revascularization added to OMT.

The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.